Neovacs S.A. (ALNEV) — Net Asset Quality Index
Neovacs S.A. (ALNEV) has a Net Asset Quality Index of 81.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €22.14 Million minus total liabilities of €4.10 Million yields net assets of €18.03 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Neovacs S.A. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Neovacs S.A. Net Asset Quality Index Over Time (2007–2025)
This chart shows how Neovacs S.A.'s Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of December 2025, the index stands at 81.5%, representing net assets of €18.03 Million against total assets of €22.14 Million EUR. Explore Neovacs S.A. cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Neovacs S.A. (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Neovacs S.A. from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ALNEV market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.5% | €18.03 Million | €22.14 Million | €4.10 Million | ▼ -0.4 pp |
| 2024 | 81.8% | €18.06 Million | €22.07 Million | €4.01 Million | ▼ -10.4 pp |
| 2023 | 92.2% | €43.82 Million | €47.53 Million | €3.71 Million | ▲ +2.4 pp |
| 2022 | 89.7% | €44.23 Million | €49.28 Million | €5.05 Million | ▼ -0.7 pp |
| 2021 | 90.4% | €43.90 Million | €48.55 Million | €4.65 Million | ▲ +9.0 pp |
| 2020 | 81.4% | €10.98 Million | €13.49 Million | €2.50 Million | ▲ +45.1 pp |
| 2019 | 36.3% | €2.74 Million | €7.54 Million | €4.80 Million | ▲ +2.7 pp |
| 2018 | 33.7% | €2.44 Million | €7.24 Million | €4.80 Million | ▲ +26.4 pp |
| 2017 | 7.2% | €845.75K | €11.67 Million | €10.82 Million | ▼ -6.2 pp |
| 2016 | 13.5% | €1.26 Million | €9.33 Million | €8.08 Million | ▼ -40.5 pp |
| 2015 | 53.9% | €6.07 Million | €11.25 Million | €5.18 Million | ▼ -7.6 pp |
| 2014 | 61.5% | €5.57 Million | €9.05 Million | €3.49 Million | ▲ +16.1 pp |
| 2013 | 45.4% | €3.48 Million | €7.67 Million | €4.19 Million | ▼ -12.9 pp |
| 2012 | 58.3% | €3.62 Million | €6.21 Million | €2.59 Million | ▼ -23.1 pp |
| 2011 | 81.4% | €10.57 Million | €12.98 Million | €2.41 Million | ▲ +3.9 pp |
| 2010 | 77.5% | €8.27 Million | €10.68 Million | €2.40 Million | ▲ +85.3 pp |
| 2009 | -7.8% | €-352.58K | €4.52 Million | €4.88 Million | ▼ -82.6 pp |
| 2008 | 74.8% | €6.51 Million | €8.70 Million | €2.19 Million | ▲ +25.6 pp |
| 2007 | 49.2% | €1.97 Million | €4.01 Million | €2.04 Million | — |